Form 8-K INTERNATIONAL FLAVORS & For: Mar 19
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
International Flavors & Fragrances (IFF) PT Raised to $85 at BofA Securities
March 20, 2024 2:10 PM EDTBofA Securities analyst Matthew DeYoe raised the price target on International Flavors & Fragrances (NYSE: IFF) to $85.00 (from $83.00) while maintaining a Neutral rating.
The analyst comments "Yesterday, IFF announced an agreement to sell its Pharma Solutions business to Roquette for $2.85bn. The transaction reflects a... More
International Flavors & Fragrances (IFF) PT Raised to $100 at Deutsche Bank
March 20, 2024 5:19 AM EDTDeutsche Bank analyst David Begleiter raised the price target on International Flavors & Fragrances (NYSE: IFF) to $100.00 (from $90.00) while maintaining a Buy rating.
The analyst comments "With the sale of Pharma Solutions, IFF has taken a major step in reducing its leverage below 3x and thus removing the leverage overhang on the shares that has existed since the... More
International Flavors & Fragrances (IFF) PT Raised to $85 at Stifel
March 19, 2024 10:24 AM EDTStifel analyst Mark Astachan raised the price target on International Flavors & Fragrances (NYSE: IFF) to $85.00 (from $80.00) while maintaining a Hold rating after selling its Pharma business for up to $2.85 billion.
The analyst commented, "IFF announced the sale of its Pharma business for up to $2.85bn,... More
